Beijing Shenzhen Zhiyao Technology Co., Ltd
Intelligent Robotics
AI-native platform for life sciences and material sciences, accelerating R&D from years to weeks. AI deeply understands biological...
About Us
Beijing Shenzhen Zhiyao Technology Co., Ltd

Company introduction
AI-native platform for life sciences and material sciences, accelerating R&D from years to weeks. AI deeply understands biological mechanisms to design proactively, not passively. It interprets pathways and targets, and drives drug design backward from clinical needs. Completed Series D financing at a multi-billion dollar valuation, backed by top-tier global investors including HongShan, CDH Investments, ZhenFund, and CITIC Capital. DIP deeply integrates large-scale AI models with scientific computing, compressing the cycle from molecular screening to candidate confirmation from years to weeks. Expert + AI collaboration: experts provide domain judgement while AI Agents handle data processing and pattern recognition for measurable performance gains. "Connect protocol design to final CSR delivery with one continuous data flow,creating a seamless end-to-end pipeline for faster global launches." DIP's AI-driven pharmaceutical R&D model has been validated by leading global industry partners, achieving sustained profitability and growth. Driving full value-chain commercialization across AI life sciences, while strengthening core competitiveness through sustained R&D investment. Transfer AI capability from life-science complex systems to materials screening, from crystal prediction to surface-energy computation. Established Japan operations as a strategic gateway for global high-standard compliance and Asia-Pacific business expansion. Established by AI scientists from global pharma giants, DIP focuses on cutting-edge innovations in AI-driven life sciences. In collaboration with a leading new-energy company, high-throughput simulation replaced years of trial-and-error. Achieved human-AI collaboration in life sciences, pioneering the era of intelligent agents in pharmaceutical R&D. A biotech used AI-assisted protocol design to achieve 12x acceleration and submit IND ahead of competitors.
Products & Solutions
Explore our products
Products & capabilities
Explore company productsCompany Channels
Explore more
About
View channelCatalog
View channelProducts
View channelNews
View channelCertifications
View channelContact
View channelBrands
View channelVideos
View channelPartners
View channelStart a Conversation
Have a project in mind?
Contact Beijing Shenzhen Zhiyao Technology Co., Ltd to discuss your requirements.